Compensation Agreements in the Life Sciences Tools & Services Industry
112 Contracts & Agreements
- 10x Genomics, Inc. (3 contracts)
- AbSci Corp (3)
- Adaptive Biotechnologies Corp (2)
- Agilent Technologies Inc (10)
- Alpha Teknova, Inc. (1)
- Berkeley Lights, Inc. (2)
- Bio-Techne (1)
- BioNano Genomics, Inc (4)
- BRUKER CORP (2)
- Cambrex Corporation (1)
- CHAMPIONS ONCOLOGY, INC. (1)
- Charles River Laboratories (5)
- ChromaDex Corp. (2)
- Codex DNA, Inc. (2)
- FLUIDIGM CORP (2)
- HARVARD BIOSCIENCE INC (11)
- HighCape Capital Acquisition Corp. (3)
- IQVIA Holdings Inc. (8)
- IsoPlexis Corp (1)
- Luminex Corporation (3)
- Medpace Holdings, Inc. (3)
- PerkinElmer (4)
- Personalis, Inc. (2)
- PRESSURE BIOSCIENCES INC (1)
- Quanterix Corp (4)
- RAPID MICRO BIOSYSTEMS, INC. (3)
- Repligen Corporation (8)
- Seer, Inc. (4)
- Sotera Health Co (1)
- Thermo Fisher Scientific (13)
- Waters Corporation (2)
- Summary of Teknova's Non-Employee Director Compensation Policy (Alpha Teknova, Inc., Filed With SEC on March 27, 2024)
- Second Amended and Restated Non-Employee Director Compensation Program (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on March 1, 2024)
- Standard BioTools Inc. Amended and Restated Outside Director Equity Compensation Policy (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
- Nonemployee Director Compensation Policy (HighCape Capital Acquisition Corp., Filed With SEC on February 29, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Quanterix Corp, Filed With SEC on February 29, 2024)
- Thermo Fisher Scientific Inc. Deferred Compensation Plan (Thermo Fisher Scientific, Filed With SEC on February 22, 2024)
- Thermo Fisher Scientific Inc. Deferred Compensation Plan for Directors of the Registrant, as amended and restated effective February 21, 2024 (Thermo Fisher Scientific, Filed With SEC on February 22, 2024)
- Repligen Corporation Amended and Restated Non-Employee Directors' Compensation Policy (Repligen Corporation, Filed With SEC on February 22, 2024)
- IQVIA Elective Deferred Compensation Plan, as amended and restated (IQVIA Holdings Inc., Filed With SEC on February 15, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (AbSci Corp, Filed With SEC on August 14, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (10x Genomics, Inc., Filed With SEC on August 4, 2023)
- Amended and Restated Non-Employee Director Compensation Program (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on August 4, 2023)
- Outside Director Compensation Policy (as amended on February 16, 2023) (Seer, Inc., Filed With SEC on May 9, 2023)
- Nonemployee Director Compensation Policy (HighCape Capital Acquisition Corp., Filed With SEC on March 17, 2023)
- Medpace Holdings, Inc. Non-Employee Director Compensation Policy revised October 21, 2022 (Medpace Holdings, Inc., Filed With SEC on February 14, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (AbSci Corp, Filed With SEC on August 11, 2022)
- Amended and Restated Outside Director Compensation Policy (Codex DNA, Inc., Filed With SEC on August 10, 2022)
- Outside Director Compensation Policy (as amended on June 15, 2022) (Seer, Inc., Filed With SEC on August 9, 2022)
- Repligen Corporation Amended and Restated Non-Employee Directors Compensation Policy (Repligen Corporation, Filed With SEC on June 1, 2022)
- Second Amendment to PerkinElmer, Inc.'s 2008 Deferred Compensation Plan, dated as of March 23, 2022, attached hereto as Exhibit 10.1 (PerkinElmer, Filed With SEC on May 10, 2022)
- Amended and Restated 2018 Non-Employee Director Compensation Policy (Quanterix Corp, Filed With SEC on March 1, 2022)
- Bionano Genomics, Inc. Non-Employee Director Compensation Policy, as amended (BioNano Genomics, Inc, Filed With SEC on March 1, 2022)
- Summary of Thermo Fisher Scientific Inc. Annual Non-Management Director Compensation (Thermo Fisher Scientific, Filed With SEC on February 24, 2022)
- Amended Personalis, Inc. Non-Employee Director Compensation Policy, dated February 17, 2022 (Personalis, Inc., Filed With SEC on February 24, 2022)
- Non-Employee Director Compensation Policy, as Amended (BioNano Genomics, Inc, Filed With SEC on November 4, 2021)
- IsoPlexis Corporation Non-Employee Director Compensation Program (IsoPlexis Corp, Filed With SEC on August 20, 2021)
- Outside Director Compensation Policy (as amended on June 16, 2021) (Seer, Inc., Filed With SEC on August 12, 2021)
- Non-Employee Director Compensation Policy (AbSci Corp, Filed With SEC on July 15, 2021)
- Non-Employee Director Compensation Program (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on July 12, 2021)
- Nonemployee Director Compensation Policy (HighCape Capital Acquisition Corp., Filed With SEC on June 15, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (10x Genomics, Inc., Filed With SEC on June 2, 2021)
- Outside Director Compensation Policy (Codex DNA, Inc., Filed With SEC on May 28, 2021)
- Repligen Corporation Amended and Restated Non-Employee Directors Compensation Policy (Repligen Corporation, Filed With SEC on May 4, 2021)
- Charles River Laboratories amended and restated Deferred Compensation Plan, as amended (Charles River Laboratories, Filed With SEC on May 4, 2021)
- Non-Employee Director Compensation Program (Berkeley Lights, Inc., Filed With SEC on March 12, 2021)
- Personalis, Inc. Non-Employee Director Compensation Policy (Personalis, Inc., Filed With SEC on February 25, 2021)
- Adaptive Biotechnologies Corporation Non-Employee Director Compensation Policy (Adaptive Biotechnologies Corp, Filed With SEC on February 24, 2021)
- Outside Director Compensation Policy (Seer, Inc., Filed With SEC on November 30, 2020)
- Non-Employee Director Compensation Policy (Sotera Health Co, Filed With SEC on November 12, 2020)
- Thermo Fisher Scientific Inc. Amended and Restated 2005 Deferred Compensation Plan, effective January 1, 2020 (Thermo Fisher Scientific, Filed With SEC on July 31, 2020)
